Riskpilot← Back to searchSign inGet full accessPharmause AB
ABActiveOrg 5592454762MalmöDiagnostic imaging services and medical laboratory activities · NACE 8691Est. 20200 employees
Revenue 2024
SEK 0
EBITDA margin
—
+98% vs 2023
Equity ratio
77.9%
Financial strength
Net profit 2024
SEK -43K
-107% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -22K | +98% |
| Net profit | SEK -43K | -107% |
| Total assets | SEK 774K | -69% |
| Equity | SEK 603K | -7% |
| Employees | 0 | — |
Legal name
Pharmause AB
Org number
5592454762
Legal form
Aktiebolag
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
2 mars 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva hjälp med konsultering vid internationell handel och därmed förenlig verksamhet.
Address
Malmö
Email
info@pharmause.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 26 032 | 118 408 | 57 604 | 4 269 | 0 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 1 011 | 21 276 | 9 370 | −1 091 | −22 |
| Depreciation & amort. | −0 | −318 | −410 | −251 | — |
| EBIT | 1 011 | 20 958 | 8 960 | −1 342 | −22 |
| Net financials | — | −113 | −115 | 127 | −21 |
| Profit before tax | 761 | 21 095 | 6 844 | 785 | −43 |
| Tax | −167 | −4 500 | −1 424 | −164 | — |
| Net profit | 594 | 16 595 | 5 420 | 621 | −43 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 807 | 34 436 | 17 239 | 2 522 | 774 |
| Equity | 2 619 | 17 214 | 5 445 | 646 | 603 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 9 938 | 17 223 | 9 793 | 1 876 | 171 |
| Total debt | 9 938 | 17 223 | 9 793 | 1 876 | 171 |
EBITDA margin
-2187600.0%
This company
15.8%
Market median
-13845670% vs market
20202024
Equity ratio
77.9%
This company
38.2%
Market median
+104% vs market
20202024
Return on equity
-7.1%
This company
18.4%
Market median
-139% vs market
20202024
Net profit margin
-4293200.0%
This company
8.1%
Market median
-53002569% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-03-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HD Audit | Audit | 2021 | — | — |
AF | Audit | 2022 | — | — |
JE Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KKDH AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KKDH AB
Pharmause AB Board members of Pharmause AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hema Dipak Joshi | Audit | 0 companies |
| Anders Filip Lundberg | Audit | 0 companies |
| Jesper Erik Ottosson | Chief Executive Officer | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Khushi Khushdeep Singh | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Sumit Duggal | Board of Directors | 0 companies |
| Prabha Duggal | Deputy Board Member | 0 companies |